{
    "paper_id": "204f95d056a9f9bcfc51009a713a36c278bce108",
    "metadata": {
        "title": "",
        "authors": [
            {
                "first": "Rita",
                "middle": [],
                "last": "Mckeever",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "During the COVID-19 pandemic, there have been many proposed medications that may be used to help treat this virus. One such medication is chloroquine/hydroxychloroquine. Numerous institutions are currently studying these drugs to see their efficacy in the treatment of COVID-19. These notes are to help in guiding the diagnosis/management of overdoses of this medication.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "These are antimalarial drugs that are also used for autoimmune diseases such as rheumatoid arthritis and lupus.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "\uf0b7 Block the synthesis of DNA and RNA and have some quinidine like cardiotoxicity o Chloroquine is 2-3 times more toxic than hydroxychloroquine o Sodium and potassium channel blockade are proposed mechanisms of cardiovascular collapse Toxic Dose:",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Mechanism of Action:"
        },
        {
            "text": "\uf0b7 Therapeutic dose of chloroquine o Prophylaxis for malaria: 500mg/week for prophylaxis o Treatment of malaria 2.5gm over 2 days \uf0b7 Reports of deaths in children after ingestion of 1-2 tabs. \uf0b7 Lethal dose in adult ~30-50mg/kg Clinical Presentation:",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Mechanism of Action:"
        },
        {
            "text": "\uf0b7 Symptom onset is rapid usually within 30min, death within 1-3 hours usually from cardiac arrest o mild to moderate \uf0a7 Dizziness, nausea/vomiting, abdominal pain, headache, visual/retinal disturbances, auditory disturbances, agitation, neuromuscular excitability \uf0a7 Can cause hemolysis in G6PD deficiency, rarely causes retinal damage, sensorineural deafness, hypoglycemia o Severe \uf0a7 Convulsions, coma, shock, respiratory/cardiac arrest \uf0a7 Quinidine-like cardiotoxicity \uf0b7 Sino-atrial node arrest, depressed myocardial contractility, QRS and/or QTc prolongation, heart block, ventricular arrythmias, ST and T wave depression, u waves \uf0a7 Hypokalemia can occur and contribute to dysrhythmias o Clinical criteria associated with fatal outcome \uf0a7 Ingestion of greater than 5gm \uf0a7 Systolic BP <80mm/Hg \uf0a7 Prolongation of QRS longer than 120 msec \uf0a7 Ventricular rhythm disturbances \uf0a7 Blood concentrations >8mcg/ml Diagnosis/Treatment: \uf0b7 Early intubation/mechanical ventilation for significant ingestions/symptoms due to seizure risk/airway protection \uf0b7 Electrolytes, glucose, BUN, creatinine, EKG and tele-monitoring \uf0b7 Treatment of QRS prolongation with sodium bicarbonate is controversial. Be mindful that alkalinization can further exacerbate hypokalemia-before using sodium bicarbonate assess full clinical picture specifically cardiac toxicity and degree of hypokalemia. \uf0b7 K repletion for severe hypokalemia (usually due to intracellular shift not overall potassium deficit)-dose with caution and frequent potassium checks as redistribution of potassium may cause a rebound hyperkalemia and may worsen cardiotoxicity o Hypokalemia correlates with severity of ingestion and occurs within a few hours of ingestion \uf0b7 Vasopressor support for hypotension not responsive to fluids o Hypotension multifactorial\uf0e0 \uf0a7 distributive from hydroxychloroquine/chloroquine induced vasodilation, \uf0a7 bradycardia from negative ionotropic effect \uf0a7 cardiogenic effects from direct cardiotoxicity o Studies done with use of epinephrine (first line treatment)-0.25mcg/kg/min and increase by 0.25mcg/kg/min until adequate BP (~100mmhg)-again monitor potassium as this can further cause intracellular shift o High dose benzos-studies done with diazepam 2mg/kg IV over 30 min after intubation then 1-2mg/kg/day \uf0b7 Avoid type 1A anti-arrhythmics \uf0b7 Extracorporeal removal methods have not been shown to be useful-as hydroxychloroquine/chloroquine have large volume of distribution and significant protein binding \uf0b7 Questionable benefit from lipid emulsion therapy-there are a few case reports that have demonstrated improvement in patients that have overdosed on these medications",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Mechanism of Action:"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Treatment of severe chloroquine poisoning",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Riou",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Barriot",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Rimailho",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "J"
                    ],
                    "last": "Baud",
                    "suffix": ""
                }
            ],
            "year": 1988,
            "venue": "N Engl J Med",
            "volume": "318",
            "issn": "",
            "pages": "1--6",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Protective cardiovascular effects of diazepam in experimental acute chloroquine poisoning",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Riou",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Rimailho",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Galliot",
                    "suffix": ""
                }
            ],
            "year": 1988,
            "venue": "Intensive Care Med",
            "volume": "14",
            "issn": "",
            "pages": "610--616",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Treatment of hydroxychloroquine overdose",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Marquardt",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "E"
                    ],
                    "last": "Albertson",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Am J Emerg Med",
            "volume": "19",
            "issn": "",
            "pages": "420--424",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Early treatment with intravenous lipid emulsion in a potentially lethal hydroxychloroquine intoxication",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ten Broeke",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Mestrom",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Woo",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kreeftenberg",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Neth J Med",
            "volume": "74",
            "issn": "",
            "pages": "210--214",
            "other_ids": {}
        }
    },
    "ref_entries": {},
    "back_matter": []
}